Immune mediated diseases and immune modulation in the neurocritical care unit
about
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeImaging and clinical properties of inflammatory demyelinating pseudotumor in the spinal cord.Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
P2860
Immune mediated diseases and immune modulation in the neurocritical care unit
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immune mediated diseases and immune modulation in the neurocritical care unit
@ast
Immune mediated diseases and immune modulation in the neurocritical care unit
@en
type
label
Immune mediated diseases and immune modulation in the neurocritical care unit
@ast
Immune mediated diseases and immune modulation in the neurocritical care unit
@en
prefLabel
Immune mediated diseases and immune modulation in the neurocritical care unit
@ast
Immune mediated diseases and immune modulation in the neurocritical care unit
@en
P2860
P1433
P1476
Immune mediated diseases and immune modulation in the neurocritical care unit
@en
P2093
Gloria von Geldern
Thomas McPharlin
P2860
P2888
P304
P356
10.1007/S13311-011-0096-3
P50
P577
2012-01-01T00:00:00Z